TickerFactsScreenerDevelopers

BioXcel Therapeutics, Inc. (BTAI) — Operating Income

Annual figures by fiscal year, from SEC filings.

2017: -$4.54M2018: -$19.96M2019: -$33.60M2020: -$82.30M2021: -$106.94M2022: -$159.65M2023: -$171.78M2024: -$67.25M2025: -$50.46M-$50.46M
2017Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$50.46M+25.0%
2024-$67.25M+60.9%
2023-$171.78M-7.6%
2022-$159.65M-49.3%
2021-$106.94M-29.9%
2020-$82.30M-144.9%
2019-$33.60M-68.3%
2018-$19.96M-340.0%
2017-$4.54M—